Form 4: C3.ai Director Stephen Ward Jr. Receives Stock Options

C3.ai Director Stephen Ward Jr. was granted 30,264 stock options with an exercise price of $19.16, vesting over two years based on board meeting attendance.

Summary

• Stephen M. Ward Jr., a Director of C3.ai, Inc. (AI), was granted 30,264 stock options.
• The options have an exercise price of $19.16 per share.
• The transaction date for this grant was October 3, 2025.
• The options will expire on October 2, 2035.
• Vesting commences on October 3, 2025, with 12.5% of the shares vesting on the last day of each fiscal quarter for two years.
• Vesting is conditional on the Reporting Person remaining a director and attending regularly scheduled board meetings in person during each fiscal quarter.
• If the director fails to attend a meeting, vesting for that quarter's shares is suspended, but these suspended shares may vest after the second anniversary of the Vesting Commencement Date if subsequent attendance requirements are met.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a Form 4 is generally neutral, this specific grant incentivizes director commitment and aligns interests with shareholders, which is a positive for corporate governance and long-term strategy.

Positives

• The grant of stock options aligns the director's financial interests with those of the shareholders, incentivizing long-term company performance.
• The vesting conditions, tied to board meeting attendance, encourage active and consistent participation from the director in corporate governance.

Risks

• The vesting of the stock options is contingent upon the director's continued service and in-person attendance at regularly scheduled board meetings; failure to meet these conditions will result in suspended vesting for that quarter's shares.

Future Outlook

The grant of stock options with a multi-year vesting schedule indicates an expectation of continued service from the director and aims to align their long-term interests with the company's performance. The vesting conditions suggest a focus on active board participation over the next two years.

Industry Context

This transaction represents a routine compensation event for a director, common across publicly traded companies to incentivize leadership and align their interests with shareholder value. Such grants are standard practice in the technology sector, where equity compensation forms a significant part of executive and director remuneration.

Comparison to Industry Standards

• Director compensation packages often include equity components like stock options or restricted stock units, which is consistent with this grant.
• Vesting schedules tied to continued service and performance (or, in this case, attendance) are standard mechanisms to retain talent and ensure commitment, aligning with practices seen in comparable technology companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Benefit from a director whose compensation is tied to the company's long-term performance and who is incentivized to actively participate in board meetings, potentially leading to better oversight and strategic decisions.
• Employees: No direct impact mentioned, but strong governance can indirectly benefit all employees through stable company leadership.

Next Steps

• Stephen M. Ward Jr. is expected to continue serving as a Director of C3.ai, Inc.
• The stock options will vest quarterly over a two-year period, contingent on the director's attendance at board meetings.

Key Dates

Recommendation

This Form 4 filing details a routine grant of stock options to a director as part of their compensation. While it aligns the director's interests with shareholders and encourages active participation, it does not present new material information that would fundamentally alter the investment thesis for C3.ai. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

C3.ai, AI, Stephen Ward Jr., Stock Options, Director Compensation, Insider Transaction, Form 4, Equity Grant, Vesting Schedule